Member Society Symposia

Molecular Signatures: Providing Clues for Management and Therapy in Transplantation, Autoimmune Diseases and Cancer

Wednesday, June 14
12:45 PM - 4:45 PM

Sponsored By: 

Advances at the molecular level continue to revolutionize our opportunities for better markers that assist in the diagnosis, prognosis and therapy selection for a variety of immune-based diseases. The approach of evaluating molecular signatures enhances our understanding of targeted diseases at the genetic and transcriptional level. This session will showcase research on the expanding interest in evaluating molecular signatures in disease processes. Our two Societies will present lectures highlighting how molecular approaches provide clues for management and therapy in autoimmune disease, cancer and transplantation.

Chairs:
Barbara Detrick, PhD; Anat Tambur, DMD, PhD

Agenda:

12:45 p.m. Introduction
Barbara Detrick, PhD, Johns Hopkins University

12:55 p.m. Biomarkers of Transplant Injury
Elaine Reed, PhD, University of California, Los Angeles

1:30 p.m. Gene Expression Profiling of the Tumor Microenvironment as a Biomarker for Anti-tumor Immunity
Thomas F. Gajewski, MD, PhD, University of Chicago

2:05 p.m. New Molecular Markers for Type 1 Diabetes
Martin J. Hessner, PhD, Medical College of Wisconsin

2:40 p.m. Antibodies and Graft Injury
Chris Wiebe, MD, University of Manitoba

3:15 p.m. - Coffee Break

3:30 p.m. Dendritic Cell Based Immunotherapy in Cancer
Willie Hildebrand, PhD, University of Oklahoma

4:05 p.m. Strategies for Therapy in SLE and RA based on Laboratory Evaluation of the Interferons
Timothy B. Niewold, MD, Mayo Clinic

Learning Objectives:


Assets

Molecular Signatures: Providing Clues for Management and Therapy in Transplantation, Autoimmune Diseases and Cancer



Attendees who have favorited this

Send Email for Molecular Signatures: Providing Clues for Management and Therapy in Transplantation, Autoimmune Diseases and Cancer